Catalyst Wire Dossier Catalyst Wire Dossier

Ellacor Micro-Coring Technology

· Cytrellis Biosystems, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ellacor Micro-Coring Technology, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

See pricing